» Articles » PMID: 15702101

Methotrexate and Oral Ulceration

Overview
Journal Br Dent J
Specialty Dentistry
Date 2005 Feb 11
PMID 15702101
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Methotrexate is well established in the drug treatment of various neoplastic diseases. More recently it has become increasingly used as a once-weekly, low-dose treatment of disorders such as psoriasis and rheumatoid arthritis. Clinical trials have shown its effectiveness in these conditions and it is likely that dentists will encounter patients taking this drug in general dental practice. Oral ulceration can occur as a side effect of methotrexate therapy. This may be due to lack of folic acid supplementation or overdosage due to confusion regarding its once-weekly regime. Illustrations of these problems, which have initially presented in a dental setting, are given. Important drug interactions of methotrexate relevant to dentistry are discussed.

Citing Articles

Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series.

Raimondo A, Di Spirito F, Lembo S Dermatol Pract Concept. 2024; 14(2).

PMID: 38810043 PMC: 11135948. DOI: 10.5826/dpc.1402a107.


From Treatment to Tragedy: Severe Methotrexate Toxicity With Mucocutaneous Ulcers, Myelosuppression, and Nephropathy.

Sawant R, Chaudhari P, Bardiya N, Acharya S, Kumar S Cureus. 2024; 16(4):e57797.

PMID: 38721177 PMC: 11077467. DOI: 10.7759/cureus.57797.


Multifocal Oral Epstein-Barr Virus-Positive Mucocutaneous Ulcers Associated with Dual Methotrexate and Leflunomide Therapy: A Case Report.

Kunmongkolwut S, Amornkarnjanawat C, Phattarataratip E Eur J Dent. 2022; 16(3):703-709.

PMID: 35016227 PMC: 9507604. DOI: 10.1055/s-0041-1739545.


Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine.

Shi G, Hu M, Chen C, Fu J, Shao S, Zhou Y Ther Adv Med Oncol. 2021; 13:1758835920987056.

PMID: 33613696 PMC: 7841859. DOI: 10.1177/1758835920987056.


Adipokines and periodontal markers as risk indicators of early rheumatoid arthritis: a cross-sectional study.

Rodriguez J, Lafaurie G, Bautista-Molano W, Chila-Moreno L, Bello-Gualtero J, Romero-Sanchez C Clin Oral Investig. 2020; 25(4):1685-1695.

PMID: 32740810 DOI: 10.1007/s00784-020-03469-0.